371 related articles for article (PubMed ID: 5737311)
1. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
[No Abstract] [Full Text] [Related]
2. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
Ceccarelli A; Leone P; Moretti A
Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
[No Abstract] [Full Text] [Related]
3. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
Ceccarelli A; Leone P
Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
[No Abstract] [Full Text] [Related]
4. [Effect of drug administration on the child with progressive muscular dystrophy].
Nakahara T; Annaka S; Baba T; Kanno M
Iryo; 1969 Oct; 23(10):1319-27. PubMed ID: 5364983
[No Abstract] [Full Text] [Related]
5. [Progressive musclar dystrophy in the experience of the Pediatric Clinic of Florence. Longitudinal study of 43 subjects].
Adami Lami Conti C; Calandi C; Nistri R; Aulisi A; Bucciolini MG; Vannelli G; Ragazzini F
Minerva Pediatr; 1981 May; 33(9):385-412. PubMed ID: 7019663
[No Abstract] [Full Text] [Related]
6. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
Radu H; Keresztes L; Stenzel K
Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841
[No Abstract] [Full Text] [Related]
7. [Myodystrophy of the Duchenne type: case reports and considerations. II. Biohumoral picture and therapy].
De Prà M
Minerva Pediatr; 1972 Feb; 24(3):100-5. PubMed ID: 5013409
[No Abstract] [Full Text] [Related]
8. Studies on enzymatic activity in serum obtained from muscular dystrophic patients.
Yamaji K; Imai H; Esaki K; Tokoro T; Hotta K
Nagoya Med J; 1968 Apr; 14(1):55-64. PubMed ID: 5696330
[No Abstract] [Full Text] [Related]
9. [Long-term hypertransaminasemia disclosing a muscular disease].
Odièvre M; Rivron M; Landrieu P
Arch Fr Pediatr; 1987; 44(6):453-4. PubMed ID: 3619584
[TBL] [Abstract][Full Text] [Related]
10. [Serum enzyme activities in the families of patients with progressive muscular dystrophy].
Tani J; Yano I; Masaki H; Fukuyama K; Saeki B
Iryo; 1967 Jul; 21(7):848-53. PubMed ID: 5582480
[No Abstract] [Full Text] [Related]
11. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
Lujf A; Sluga E; Moser K
Wien Klin Wochenschr; 1971 Feb; 83(7):109-13. PubMed ID: 5547427
[No Abstract] [Full Text] [Related]
12. [Progressive muscular dystrophy: CPK, LDH, ALD (aldolase)--EMG, ECG in patients and their families].
Diotallevi P; Bargilli E; Danni M; Dellantonio R; Tocchini M; Milani-Comparetti M
Boll Soc Ital Biol Sper; 1988 Jun; 64(6):523-30. PubMed ID: 3190905
[No Abstract] [Full Text] [Related]
13. [Evaluation of serum pyruvate kinase in patients with Duchenne's muscular dystrophy and carriers. Comparison with other enzyme determinations].
Calandi C; Adami Lami C; Guidotti T; Nistri R; Papuzza S; Tozzi P; Poggi G
Minerva Pediatr; 1981 May; 33(10):453-64. PubMed ID: 7254147
[No Abstract] [Full Text] [Related]
14. [Further acquisitions and research on primary myodystrophies. I. Some findings on the therapy of pseudohypertrophic progressivemuscular dystrophy with sodium lactate].
Cacciari E; Tassoni P; Comellini L; Mei V; Corsini F
Boll Soc Ital Biol Sper; 1967 Jan; 43(2):90-2. PubMed ID: 6049576
[No Abstract] [Full Text] [Related]
15. [Serum enzyme activities in progressive muscular dystrophy].
Yano I; Furukawa Y; Masaki H; Tani J
Nihon Rinsho; 1966 Mar; 24(3):571-5. PubMed ID: 6007312
[No Abstract] [Full Text] [Related]
16. [Clinico-biochemical and genetic studies of myopathy].
Davidenkova EF; Droznina TA; Markelov IM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(11):1623-8. PubMed ID: 6001049
[No Abstract] [Full Text] [Related]
17. Slowly progressive X-linked recessive muscular dystrophy (type 3b). Report of cases and review of the literature.
Zellweger H; Hanson JW
Arch Intern Med; 1967 Nov; 120(5):525-35. PubMed ID: 6054585
[No Abstract] [Full Text] [Related]
18. [The treatment of muscular dystrophy with the nucleoside-nucleotide mixture Laevadosine].
Radu H; Stenzel K; Migea S; Bordeianu L
Munch Med Wochenschr; 1967 Dec; 109(51):2702-5. PubMed ID: 4873261
[No Abstract] [Full Text] [Related]
19. Biochemical aspects of genetically determined progressive muscular dystrophies.
Luca N; Haţegan D
Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
[No Abstract] [Full Text] [Related]
20. [Muscle enzymes in the serum during juvenile progressive polyarthritis].
Havelka S; Továrek J; Rádl J
Fysiatr Revmatol Vestn; 1969; 47(4):165-8. PubMed ID: 5816407
[No Abstract] [Full Text] [Related]
[Next] [New Search]
